Last 48 quarters of trend data · Healthcare · Medical - Healthcare Plans
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
CVS Health Corporation's quarterly P/E stands at 7.8x, down 35.0% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 19.9% YoY to 6.9x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 62.81 | 7.81 | 8.63 | — | 21.56 | 12.01 | 8.63 | 227.50 | 10.47 | 22.66 | 12.42 | 9.97 | 11.68 |
| — | -35.0% | -0.1% | — | +105.9% | -47.0% | -30.5% | +2180.8% | -10.3% | +101.3% | -5.7% | — | +15.4% | |
| P/S Ratio | 0.28 | 0.23 | 0.24 | 0.23 | 0.22 | 0.23 | 0.14 | 0.21 | 0.20 | 0.29 | 0.27 | 0.25 | 0.25 |
| — | +1.0% | +65.5% | +12.1% | +8.7% | -20.8% | -46.8% | -17.3% | -18.5% | +1.6% | -25.8% | -35.1% | -34.1% | |
| P/B Ratio | 1.47 | 1.18 | 1.34 | 1.31 | 1.13 | 1.11 | 0.75 | 1.05 | 0.99 | 1.36 | 1.33 | 1.21 | 1.22 |
| — | +6.5% | +79.9% | +24.1% | +14.1% | -18.5% | -43.9% | -12.8% | -18.8% | +1.7% | -22.2% | -31.6% | -24.8% | |
| P/FCF | 14.27 | 6.75 | 9.72 | 244.06 | 16.98 | 5.61 | 12.96 | — | 7.58 | 6.02 | — | 10.37 | 4.18 |
| — | +20.3% | -25.0% | — | +123.9% | -6.7% | — | — | +81.3% | +61.9% | — | +182.6% | -31.2% | |
| EV / EBITDA | 13.11 | 6.93 | 14.30 | — | 11.16 | 8.66 | 9.31 | 19.44 | 8.68 | 12.69 | 9.61 | 8.15 | 9.07 |
| — | -19.9% | +53.6% | — | +28.6% | -31.8% | -3.1% | +138.4% | -4.3% | +43.1% | -0.7% | — | +13.1% | |
| EV / EBIT | 18.92 | 8.52 | 21.77 | — | 16.45 | 11.52 | 11.37 | 45.21 | 11.87 | 18.84 | 12.76 | 10.58 | 12.08 |
| — | -26.0% | +91.5% | — | +38.6% | -38.9% | -10.9% | +327.3% | -1.7% | +65.6% | +3.4% | — | +23.4% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
CVS Health Corporation's operating margin was 4.7% in Q1 2026, up 2.7 pp QoQ and up 1.1 pp YoY. This marks the 3rd consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency. The trailing four-quarter average of 1.5% lags the current quarter, suggesting the recent improvement is above-trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.8% | 15.6% | 12.8% | 13.4% | 13.7% | 15.2% | 13.2% | 13.2% | 14.7% | 14.2% | 14.8% | 15.1% | 15.3% |
| — | +2.2% | -2.8% | +2.0% | -6.3% | +7.2% | -10.7% | -13.0% | -4.1% | -9.4% | -10.2% | -8.3% | -11.0% | |
| Operating Margin | 2.6% | 4.7% | 2.0% | -3.1% | 2.4% | 3.6% | 2.4% | 0.9% | 3.3% | 2.6% | 3.6% | 4.1% | 3.6% |
| — | +30.6% | -17.5% | -457.6% | -27.9% | +38.9% | -32.6% | -78.8% | -8.2% | -36.5% | -16.7% | +185.1% | -37.2% | |
| Net Margin | 0.4% | 2.9% | 2.8% | -3.9% | 1.0% | 1.9% | 1.7% | 0.1% | 1.9% | 1.3% | 2.2% | 2.5% | 2.1% |
| — | +55.8% | +65.5% | -4337.0% | -46.8% | +49.4% | -22.9% | -96.4% | -9.3% | -49.8% | -20.6% | +160.0% | -43.1% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 2.3% | 3.8% | 4.0% | -5.3% | 1.3% | 2.3% | 2.2% | 0.1% | 2.4% | 1.5% | 2.7% | 3.1% | 2.6% |
| — | +65.2% | +81.8% | -4656.7% | -44.3% | +57.7% | -19.5% | -96.2% | -9.8% | -50.5% | -16.0% | +165.9% | -35.0% | |
| ROA | 0.7% | 1.1% | 1.1% | -1.5% | 0.4% | 0.7% | 0.7% | 0.0% | 0.7% | 0.4% | 0.8% | 0.9% | 0.8% |
| — | +63.7% | +75.3% | -4586.1% | -43.6% | +56.9% | -20.4% | -96.2% | -9.3% | -51.2% | -18.5% | +161.1% | -40.6% | |
| ROIC | 5.0% | 2.3% | 1.0% | -1.6% | 1.2% | 1.7% | 1.2% | 0.4% | 1.6% | 1.2% | 1.7% | 2.0% | 1.8% |
| — | +34.8% | -12.3% | -489.6% | -22.9% | +46.4% | -32.5% | -78.5% | -11.6% | -41.0% | -18.0% | +187.4% | -29.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
CVS Health Corporation's Debt/EBITDA ratio is 13.5x, down from 28.7x last quarter — elevated, raising questions about debt serviceability. The current ratio has improved 5.2% YoY to 0.87x, strengthening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.24 | 1.01 | 1.24 | 1.12 | 1.07 | 1.05 | 1.09 | 1.10 | 1.12 | 1.10 | 1.04 | 1.07 | 1.13 |
| — | -4.2% | +13.4% | +1.5% | -4.4% | -4.5% | +5.7% | +2.4% | -0.8% | +3.2% | +5.1% | +7.4% | +14.5% | |
| Debt / EBITDA | 6.24 | 13.52 | 28.72 | — | 23.29 | 17.94 | 23.59 | 41.50 | 19.98 | 23.99 | 17.61 | 16.63 | 18.93 |
| — | -24.6% | +21.7% | — | +16.6% | -25.2% | +33.9% | +149.6% | +5.5% | +39.5% | +16.2% | — | +46.8% | |
| Current Ratio | 0.84 | 0.87 | 0.84 | 0.83 | 0.80 | 0.82 | 0.81 | 0.80 | 0.86 | 0.81 | 0.86 | 0.86 | 0.86 |
| — | +5.2% | +3.8% | +4.5% | -6.5% | +1.6% | -5.3% | -7.5% | +0.5% | -11.5% | -9.4% | -8.9% | -5.8% | |
| Quick Ratio | 0.63 | 0.66 | 0.63 | 0.63 | 0.62 | 0.63 | 0.60 | 0.59 | 0.66 | 0.61 | 0.63 | 0.64 | 0.64 |
| — | +5.2% | +4.7% | +6.8% | -6.6% | +2.2% | -5.1% | -8.2% | +3.9% | -8.7% | -6.1% | -7.8% | -2.6% | |
| Interest Coverage | 1.68 | 6.09 | 2.72 | -3.44 | 3.16 | 4.33 | 3.80 | 1.14 | 4.19 | 3.21 | 4.92 | 5.36 | 4.75 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying CVS stock.
CVS Health Corporation's current P/E is 62.8x. The average P/E over the last 3 quarters is 12.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
CVS Health Corporation's current operating margin is 2.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking CVS Health Corporation's business trajectory between earnings reports.